Skip to content

Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study

Robert Gramling, Emily Bennett, Keith Curtis, William Richards, Donna M Rizzo, Francesca Arnoldy, Logan Hegg, Jon Porter, Heather Honstein, Susanna Pratt, Elise C. Tarbi, Maija Reblin, Paul Thambi, Manish Agrawal

Journal of Palliative Medicine August 17, 2023 DOI: 10.1089/jpm.2023.0189 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational feasibility study Peer reviewed
Population Participants in a psilocybin-assisted therapy clinical trial
Intervention Psilocybin-assisted therapy
Duration 8-hour encounters
Topics Psilocybin Psychedelic-assisted therapy
Keywords Communication Empathy Therapeutic relationship Hallucinogen therapy Therapeutic bond Client-therapist relationship Physical
Citations 6
Key findings Direct observation of therapeutic connection during psilocybin-assisted therapy is feasible and sensitive to changes in states of consciousness, requiring both audible and visual data.

Abstract

Context: Measuring therapeutic connection during psilocybin-assisted therapy is essential to understand underlying mechanisms, inform training, and guide quality improvement.

Purpose: To evaluate the feasibility of directly observing indicators of therapeutic connection during psilocybin administration encounters.

Methods: We evaluated audio and video data from a recent clinical trial for observable expressions of therapeutic connection as defined in proposed best-practice competencies (i.e., empathic abiding presence and interpersonal grounding). We selected the first four 8-hour encounters involving unique participants, therapists, and gender pairs. Each video was independently coded by three members of an interprofessional six-person team. Using a structured checklist, coders recorded start–stop times, the audible (i.e., speech prosody or words) and visible (i.e., body movements, eye gaze, and touch) cues marking the event, and the qualities of the interaction (e.g., expression of awe, trust, distress, and calmness). We assessed feasibility by observing the frequency, distribution, and overlap of cues and qualities coders used to identify and define moments of therapeutic connection.

Results: Among the 2074 minutes of video, coders recorded 372 moments of therapeutic connection. Eighty-three percent were identified by at least two coders and 41% by all three. Coders used a combination of audible and visual cues to identify therapeutic connection in 51% of observed events (190/372). Both the cues and qualities of therapeutic connection expressions varied over the course of psilocybin temporal effects on states of consciousness.

Conclusion: Direct observation of therapeutic human connection is feasible, sensitive to changes in states of consciousness and requires evaluation of audible and visual data.

Comparable studies

Other observational and cohort studies on psilocybin and psychedelic-assisted therapy, most cited first.

Study Year Design Participants
Acute subjective effects in LSD- and MDMA-assisted psychotherapy Patients with psychiatric disorders (posttraumatic stress disorder and major... 2020 Observational study n = 18
Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression. 17 patients with treatment-resistant depression and 18 untreated age-matched healthy... 2018 Observational cohort with machine learning classification n = 35
Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity. Patients with treatment-resistant depression or moderate-to-severe major depression 2024 Observational cohort n = 38
The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov. Psilocybin clinical trials listed on ClinicalTrials.gov 2024 Observational study n = 134
Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response 28 PAT patients and 28 healthy volunteers 2024 Observational cohort with comparison group n = 56

Explore topics

By condition and practice